128 related articles for article (PubMed ID: 3160233)
1. The control of hepatitis B virus infection with vaccine in Yupik Eskimos. Demonstration of safety, immunogenicity, and efficacy under field conditions.
Heyward WL; Bender TR; McMahon BJ; Hall DB; Francis DP; Lanier AP; Alward WL; Ahtone JL; Murphy BL; Maynard JE
Am J Epidemiol; 1985 Jun; 121(6):914-23. PubMed ID: 3160233
[TBL] [Abstract][Full Text] [Related]
2. Duration of immunogenicity and efficacy of hepatitis B vaccine in a Yupik Eskimo population.
Wainwright RB; McMahon BJ; Bulkow LR; Hall DB; Fitzgerald MA; Harpster AP; Hadler SC; Lanier AP; Heyward WL
JAMA; 1989 Apr; 261(16):2362-6. PubMed ID: 2523002
[TBL] [Abstract][Full Text] [Related]
3. Protection provided by hepatitis B vaccine in a Yupik Eskimo population--results of a 10-year study.
Wainwright RB; Bulkow LR; Parkinson AJ; Zanis C; McMahon BJ
J Infect Dis; 1997 Mar; 175(3):674-7. PubMed ID: 9041341
[TBL] [Abstract][Full Text] [Related]
4. Protection provided by hepatitis B vaccine in a Yupik Eskimo population. Seven-year results.
Wainwright RB; McMahon BJ; Bulkow LR; Parkinson AJ; Harpster AP
Arch Intern Med; 1991 Aug; 151(8):1634-6. PubMed ID: 1831343
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of hepatitis B in selected Alaskan Eskimo villages.
Schreeder MT; Bender TR; McMahon BJ; Moser MR; Murphy BL; Sheller MJ; Heyward WL; Hall DB; Maynard JE
Am J Epidemiol; 1983 Oct; 118(4):543-9. PubMed ID: 6637981
[TBL] [Abstract][Full Text] [Related]
6. Persistence of antibody to hepatitis B and protection from disease among Alaska natives immunized at birth.
Dentinger CM; McMahon BJ; Butler JC; Dunaway CE; Zanis CL; Bulkow LR; Bruden DL; Nainan OV; Khristova ML; Hennessy TW; Parkinson AJ
Pediatr Infect Dis J; 2005 Sep; 24(9):786-92. PubMed ID: 16148845
[TBL] [Abstract][Full Text] [Related]
7. Response to hepatitis B vaccine in Alaska natives with chronic alcoholism compared with non-alcoholic control subjects.
McMahon BJ; Wainwright K; Bulkow L; Parkinson AJ; Lindenbaum M; Wainwright R; Helminiak C
Am J Med; 1990 May; 88(5):460-4. PubMed ID: 2140010
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of isolated antibody to hepatitis B core antigen in an area endemic for hepatitis B virus infection: implications in hepatitis B vaccination programs.
Lok AS; Lai CL; Wu PC
Hepatology; 1988; 8(4):766-70. PubMed ID: 2968945
[TBL] [Abstract][Full Text] [Related]
9. Vasculitis in Eskimos living in an area hyperendemic for hepatitis B.
McMahon BJ; Bender TR; Templin DW; Maynard JE; Barrett DH; Berquist KR; Lum MK; Mann CC
JAMA; 1980 Nov; 244(19):2180-2. PubMed ID: 7420721
[TBL] [Abstract][Full Text] [Related]
10. Long-term efficacy of continuing hepatitis B vaccination in infancy in two Gambian villages.
Whittle HC; Maine N; Pilkington J; Mendy M; Fortuin M; Bunn J; Allison L; Howard C; Hall A
Lancet; 1995 Apr; 345(8957):1089-92. PubMed ID: 7715343
[TBL] [Abstract][Full Text] [Related]
11. Hepatitis B vaccine in pregnancy: immunogenicity, safety and transfer of antibodies to infants.
Ayoola EA; Johnson AO
Int J Gynaecol Obstet; 1987 Aug; 25(4):297-301. PubMed ID: 2887464
[TBL] [Abstract][Full Text] [Related]
12. Antibody levels and protection after hepatitis B vaccination: results of a 15-year follow-up.
McMahon BJ; Bruden DL; Petersen KM; Bulkow LR; Parkinson AJ; Nainan O; Khristova M; Zanis C; Peters H; Margolis HS
Ann Intern Med; 2005 Mar; 142(5):333-41. PubMed ID: 15738452
[TBL] [Abstract][Full Text] [Related]
13. [Study on the variations of hepatitis B virus status among people having received hepatitis B vaccine].
Shen LP; Yang JY; Mo ZJ; Li RC; Li YP; Wei ZL; Dong YH; Zhou KJ; Wei SC; Fang KX; Yu T; Zhang WY; Zhang Y; Bi SL
Zhonghua Liu Xing Bing Xue Za Zhi; 2007 Jul; 28(7):659-62. PubMed ID: 18069553
[TBL] [Abstract][Full Text] [Related]
14. Epidemiology of hepatitis B in two Alaska communities.
Barrett DH; Burks JM; McMahon B; Elliott S; Berquist KR; Bender TR; Maynard JE
Am J Epidemiol; 1977 Feb; 105(2):118-22. PubMed ID: 835563
[TBL] [Abstract][Full Text] [Related]
15. The safety and immunogenicity of a recombinant hepatitis B vaccine in neonates.
Gunn TR; Bosley A; Woodfield DG
N Z Med J; 1989 Jan; 102(860):1-3. PubMed ID: 2521527
[TBL] [Abstract][Full Text] [Related]
16. Hepatitis B Virus Revaccination With Standard Versus Pre-S Vaccine in Previously Immunized Patients With Celiac Disease.
Heshin-Bekenstein M; Turner D; Shamir R; Bar-Meir M; Dagan R; Zevit N; Silbermintz A
J Pediatr Gastroenterol Nutr; 2015 Oct; 61(4):400-3. PubMed ID: 25988560
[TBL] [Abstract][Full Text] [Related]
17. Continuing Decrease in Hepatitis B Virus Infection 30 Years After Initiation of Infant Vaccination Program in Taiwan.
Ni YH; Chang MH; Jan CF; Hsu HY; Chen HL; Wu JF; Chen DS
Clin Gastroenterol Hepatol; 2016 Sep; 14(9):1324-30. PubMed ID: 27155556
[TBL] [Abstract][Full Text] [Related]
18. [Respective importance of vertical and horizontal transmission of hepatitis B in the Australian archipelago (French Polynesia). Preliminary results of the vaccination of newborns].
Boutin JP; Spiegel A; Flye Sainte-Marie F; Cartel JL; Girard M; Saliou P; Roux J
Bull Soc Pathol Exot; 1991; 84(5 Pt 5):906-11. PubMed ID: 1840244
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of recombinant hepatitis B vaccine in infants born to HBsAg-positive mothers.
Yeoh EK; Chang WK; Ip P; Chan KH; Chan E; Fung C
J Infect; 1986 Jul; 13 Suppl A():15-8. PubMed ID: 2943811
[TBL] [Abstract][Full Text] [Related]
20. [A preliminary study on response to hepatitis B vaccine in subjects with various levels of antibody to hepatitis B surface antigen].
Liu KZ
Zhonghua Yu Fang Yi Xue Za Zhi; 1989 May; 23(3):132-4. PubMed ID: 2582918
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
